FT-ICR mass spectrometry in the drug discovery process
- 1 May 2005
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 10 (9), 635-642
- https://doi.org/10.1016/s1359-6446(05)03438-0
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- FTICR mass spectrometry for qualitative and quantitative bioanalysesCurrent Opinion in Biotechnology, 2004
- Nano‐high‐performance liquid chromatography in combination with nano‐electrospray ionization Fourier transform ion‐cyclotron resonance mass spectrometry for proteome analysisRapid Communications in Mass Spectrometry, 2003
- Analysis of complex protein–polypeptide systems for proteomic studiesJournal of Chromatography B, 2003
- Characterisation of combinatorial libraries of mucin‐2 antigen peptides by high‐resolution mass spectrometryRapid Communications in Mass Spectrometry, 2002
- Broadband Detection Electrospray Ionization Fourier Transform Ion Cyclotron Resonance Mass Spectrometry To Reveal Enzymatically and Chemically Induced Deamidation Reactions within PeptidesAnalytical Chemistry, 2001
- Fourier transform ion cyclotron resonance mass spectrometry: A primerMass Spectrometry Reviews, 1998
- Sequential mass spectrometry and MSn analyses of combinatorial libraries by using automated matrix-assisted laser desorption/ionization Fourier transform mass spectrometryRapid Communications in Mass Spectrometry, 1998
- Reverse‐phase liquid chromatography/electrospray‐ionization Fourier‐transform mass spectrometry in the analysis of peptidesRapid Communications in Mass Spectrometry, 1994
- Multiple excitation collisional activation in Fourier‐transform mass spectrometryRapid Communications in Mass Spectrometry, 1993
- Matrix‐assisted laser desorption/ionization of high‐mass molecules by Fourier‐transform mass spectrometryRapid Communications in Mass Spectrometry, 1992